Vitrolife AB (CHIX:VITRS) 5-Day RSI: N/A (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:VITRS Vitrolife AB CHIX:VITRS
73 GF Score
Price kr86.38
GF Value kr179.20
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB 5-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-08-17), Vitrolife AB's 5-Day RSI is N/A.

The industry rank for Vitrolife AB's 5-Day RSI or its related term are showing as below:

CHIX:VITRs's 5-Day RSI is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 53.84
* Ranked among companies with meaningful 5-Day RSI only.

Vitrolife AB  (CHIX:VITRs) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Vitrolife AB 5-Day RSI Related Terms


CHIX:VITRS vs ABT, SYK, MDT: 5-Day RSI Comparison

For the Medical Devices subindustry, Vitrolife AB's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB 5-Day RSI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's 5-Day RSI falls into.


CHIX:VITRS
73GF Score
Vitrolife AB CHIX:VITRS
5-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB  (CHIX:VITRs) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Vitrolife AB (CHIX:VITRS) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of kr86.38 is trading 51.8% below its estimated GF Value™ of kr179.20. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for CHIX:VITRS:

  • 5-Day RSI: N/A
  • GF Value™: kr179.20 vs. price of kr86.38 (51.8% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the CHIX:VITRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
73GF Score

Get the complete analysis for CHIX:VITRS

5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr86.38
Price
kr179.20
GF Value